Refractory Malignant Solid Tumors
2 clinical trials · Condition
◉ Watch Refractory Malignant Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors. (NCT07040943) | West China Hospital | 2025-06-29 |
| A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity (NCT07100210) | Xingchen Peng | 2025-01-20 |
Track Refractory Malignant Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.